This discrepancy isn't shared with other dopamine reuptake inhbitors like bupropion, sibutramine, mazindol or tesofensine, that have similar or larger potencies than copyright as dopamine reuptake inhibitors. These results have evoked a speculation that copyright can also perform as a so-referred to as "DAT inverse agonist" or "unfavorable allosteric modifier https://joyceq974tsd3.daneblogger.com/profile